Literature DB >> 18280405

Treatment of retinopathy of prematurity.

David Clark1, K Mandal.   

Abstract

Retinopathy of prematurity is a potentially blinding disorder of premature infants. Retinal ablation of the avascular retina originally described using cryotherapy but now most commonly undertaken with laser photocoagulation, reduces the unfavourable structural outcomes and improves the functional visual acuity outcome. The CRYO-ROP study showed the long-term benefit of treatment of threshold disease compared with no treatment, however even with cryoablation 44.4% of treated eyes had a visual acuity of 6/60 or worse at 10 year follow-up. The ETROP study of earlier treatment for high-risk pre-threshold disease, rather than treatment at threshold, has shown that pre-threshold treatment of type 1 disease produces a significantly improved outcome. Despite treatment some infants develop retinal detachment for which various surgical treatments have been described, although not always with a good functional outcome. Future treatment modalities may include the use of anti-VEGF therapies.

Entities:  

Mesh:

Year:  2008        PMID: 18280405     DOI: 10.1016/j.earlhumdev.2007.11.007

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  14 in total

Review 1.  Laser treatment for retinopathy of prematurity.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2011-12-02       Impact factor: 3.161

Review 2.  Adenosine receptors and caffeine in retinopathy of prematurity.

Authors:  Jiang-Fan Chen; Shuya Zhang; Rong Zhou; Zhenlang Lin; Xiaohong Cai; Jing Lin; Yuqing Huo; Xiaoling Liu
Journal:  Mol Aspects Med       Date:  2017-01-11

3.  Caffeine preferentially protects against oxygen-induced retinopathy.

Authors:  Shuya Zhang; Rong Zhou; Bo Li; Haiyan Li; Yanyan Wang; Xuejiao Gu; Lingyun Tang; Cun Wang; Dingjuan Zhong; Yuanyuan Ge; Yuqing Huo; Jing Lin; Xiao-Ling Liu; Jiang-Fan Chen
Journal:  FASEB J       Date:  2017-04-18       Impact factor: 5.191

4.  Pulmonary surfactant protein a is expressed in mouse retina by Müller cells and impacts neovascularization in oxygen-induced retinopathy.

Authors:  Faizah Bhatti; Genevieve Ball; Ronald Hobbs; Annette Linens; Saad Munzar; Rizwan Akram; Alistair J Barber; Michael Anderson; Michael Elliott; Madeline Edwards
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-18       Impact factor: 4.799

5.  Deficiency of aldose reductase attenuates inner retinal neuronal changes in a mouse model of retinopathy of prematurity.

Authors:  Zhongjie Fu; Shen Nian; Suk-Yee Li; David Wong; Sookja K Chung; Amy C Y Lo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-29       Impact factor: 3.117

6.  Infection, oxygen, and immaturity: interacting risk factors for retinopathy of prematurity.

Authors:  Minghua Chen; Ayse Citil; Frank McCabe; Katherine M Leicht; John Fiascone; Christiane E L Dammann; Olaf Dammann
Journal:  Neonatology       Date:  2010-08-24       Impact factor: 4.035

7.  Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.

Authors:  Shuya Zhang; Haiyan Li; Bo Li; Dingjuan Zhong; Xuejiao Gu; Lingyun Tang; Yanyan Wang; Cun Wang; Rong Zhou; Yan Li; Yan He; Mozi Chen; Yuqing Huo; Xiao-Ling Liu; Jiang-Fan Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

8.  Genetic inactivation of the adenosine A2A receptor attenuates pathologic but not developmental angiogenesis in the mouse retina.

Authors:  Xiao-Ling Liu; Rong Zhou; Qi-Qi Pan; Xiao-Lin Jia; Wei-Na Gao; Jun Wu; Jing Lin; Jiang-Fan Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-07       Impact factor: 4.799

9.  Long term visual outcomes in laser treated threshold retinopathy of prematurity in Central Saudi Arabia.

Authors:  Abdullah G Al-Otaibi; Sultan S Aldrees; Ahmed A Mousa
Journal:  Saudi J Ophthalmol       Date:  2012-06-07

Review 10.  The progress of prophylactic treatment in retinopathy of prematurity.

Authors:  Hong-Bing Zhang; Xiao-Dong Wang; Kun Xu; Xiao-Gang Li
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.